Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 8Phase EARLY_PHASE1 6Phase 4 4Phase 1/2 3Phase 1 3Phase 3 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 1863INDUSTRY 553OTHER_GOV 81NIH 17FED 15NETWORK 12UNKNOWN 7INDIV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Warts 1Lymphoma, Follicular 1Leiomyoma 1Hypotrichosis 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

ethyl pyruvate 1compound W 1Salicylates 1Bimatoprost 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × INDIV × Clear all
NCT05178303 2025-05-16

SB-1121

Trieu, Nguyen Thi, M.D.

Phase 4 Completed
134 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02620345 2015-12-03

Fibroids

Trieu, Nguyen Thi, M.D.

Phase 4 Completed
22 enrolled

Leiomyoma

NCT01712295 2012-10-23

17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

Grossman, Michael, D.P.M.

Phase 4 Unknown
100 enrolled

Warts

NCT01387906 2012-06-15

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Beer, Kenneth R., M.D., PA

Phase 4 Completed
20 enrolled
Lymphoid

Hypotrichosis, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡